Sleep terrors [night terrors]

F5_SLEEPTERRORS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51.4 Cause of death: ICD-10 — F51.4 2 out of 7 registries used, show all original rules.	83
4. Check minimum number of events None	83
5. Include endpoints None	83
6. Filter based on genotype QC (FinnGen only)	83

Control definitions (FinnGen only)

Control exclude: F5_SLEEP

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_SLEEPTERRORS
CONTROL_EXCLUDE	F5_SLEEP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F514
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F514
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep terrors [night terrors] based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1681	662	1017
Only index persons	1307	520	787
Unadjusted period prevalence (%)
Whole population	0.02	0.02	0.03
Only index persons	0.03	0.02	0.03
Median age at first event (years)
Whole population	6.64	6.09	6.94
Only index persons	7.71	7.32	7.97

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	83	63	20
Unadjusted period prevalence (%)	0.02	0.02	0.01
Median age at first event (years)	14.48	16.02	9.61

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
73: Matched controls
730

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

+∞

104.9

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

+∞

12.9

G47.9

ICD-10 Finland

Sleep disorder, unspecified

42.5

9.3

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

+∞

7.4

Z01.8

ICD-10 Finland

Other specified special examinations

4.7

6.6

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

+∞

6.3

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

+∞

6.3

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

148

2.75

4.43

2.0

1.9

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

4.22

3.95

1.9

1.4

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2.89

3.85

3.2

1.1

0.6

e6/l

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

263

2.43

3.84

2.7

2.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

187

2.39

3.50

6.1

3.2

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

157

2.43

3.44

4.2

3.2

—

(3011288) Drugs identified in Urine by Screen method

2.96

3.27

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2.68

3.25

3.0

3.3

2.6

4.6

e6/l

—

(36304419) Bacteria [Presence] in Urine

161

2.35

3.23

6.2

2.9

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

283

2.18

3.03

3.3

2.7

—

(42870588) Differential panel, method unspecified - Blood

206

2.21

3.00

4.1

7.1

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

2.49

2.83

1.3

53.1

25.2

iu/ml

—

(3015736) pH of Urine

262

2.12

2.81

3.7

3.0

—

(3030467) Casts [#/volume] in Urine by Automated count

159

2.15

2.56

6.5

3.1

0.1

0.2

e6/l

0.56

119

(3021601) Nitrite [Presence] in Urine by Test strip

326

2.02

2.50

6.1

4.9

0.0

estimate

—

(3035350) Ketones [Presence] in Urine by Test strip

326

2.02

2.50

4.9

3.3

0.0

estimate

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2.32

2.40

1.4

1.3

16.5

9.6

u/ml

—

(3002582) Erythrocytes [#/volume] in Urine

180

2.04

2.36

6.1

3.0

20.3

93.9

e6/l

1.23

137

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

172

2.05

2.35

2.6

1.6

94.3

87.7

pmol/l

0.35

102

(3009261) Glucose [Presence] in Urine by Test strip

331

1.97

2.34

5.1

3.5

0.0

estimate

—

(40768804) Tissue Pathology biopsy report

199

1.99

2.27

1.6

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

183

2.00

2.24

2.4

2.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

299

1.91

2.18

2.7

1.8

—

(3000850) Epithelial cells [#/volume] in Urine

121

2.11

2.15

6.1

2.2

10.5

9.2

e6/l

0.16

106

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

203

1.94

2.12

3.8

3.4

22.7

28.5

u/l

1.83

192

(3044889) 12 lead EKG panel

311

1.88

2.10

3.2

2.4

—

(3018095) Leukocytes [#/volume] in Urine

221

1.91

2.09

6.8

3.6

19.4

53.7

e6/l

0.96

143

(3006315) Basophils [#/volume] in Blood

331

1.87

2.06

4.2

6.2

0.0

e9/l

0.43

295

(3001604) Monocytes [#/volume] in Blood

331

1.87

2.06

4.2

6.2

0.5

e9/l

0.06

295

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

4.76

1.97

1.0

1.3

—

(40761535) Cells panel - Urine sediment

2.71

1.91

4.0

3.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.25

1.89

1.9

1.6

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

2.31

1.89

1.6

1.8

328.6

376.4

nmol/l

0.41

(3019198) Lymphocytes [#/volume] in Blood

357

1.82

1.88

4.1

6.1

1.9

2.1

e9/l

0.74

322

(3016879) Cocaine [Presence] in Urine

2.15

1.79

2.4

2.2

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.38

1.77

1.2

1.7

—

(3027008) Opiates [Presence] in Urine

2.09

1.76

2.3

2.1

—

(3013115) Eosinophils [#/volume] in Blood

343

1.77

1.74

5.1

6.7

0.1

0.2

e9/l

1.68

308

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

155

1.88

1.73

2.0

1.8

2.9

2.7

mg/l

0.17

130

(3028300) Cannabinoids [Presence] in Urine

2.07

1.71

2.3

2.2

—

(3027944) Amphetamines [Presence] in Urine

2.07

1.71

2.3

2.2

—

(3000764) Benzodiazepines [Presence] in Urine

2.07

1.71

2.3

2.1

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

2.20

1.71

1.6

2.0

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

3.73

1.64

13.8

19.4

1.3

1.1

mg/l

—

(3026782) Osmolality of Urine

110

1.94

1.60

6.7

2.4

539.5

569.9

mosm/kgh2o

0.23

(3000494) Fungus identified in Specimen by Culture

2.19

1.59

1.5

1.8

—

(40768797) Stomach Pathology biopsy report

2.33

1.58

1.5

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

3.48

1.54

1.8

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

3.48

1.54

1.0

1.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

155

1.77

1.44

4.4

2.9

50.3

52.1

u/l

0.15

145

(3025941) Bacteria identified in Stool by Culture

2.54

1.42

1.1

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.34

1.42

2.7

5.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

2.01

1.40

2.5

2.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

219

1.66

1.35

7.3

9.3

1.2

mmol/l

0.10

183

(4010399)

2.49

1.33

1.5

1.3

—

(3028707) Methadone [Presence] in Urine by Screen method

2.17

1.31

2.7

2.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2.89

1.30

1.0

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

463

1.64

1.27

6.4

3.9

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

135

1.74

1.27

4.0

2.2

9.9

12.3

ng/l

—

(3042936) Bacteria identified in Isolate by Culture

2.02

1.25

1.8

2.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

2.16

1.19

1.9

2.2

—

(3019060) Gas panel - Arterial blood

2.59

1.17

1.6

29.7

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

2.59

1.17

1.0

1.2

—

(3045414) Leukocytes [Presence] in Urine

2.45

1.15

1.9

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.00

1.13

1.1

1.7

—

(3009542) Hematocrit [Volume Fraction] of Blood

672

1.93

1.13

17.6

11.1

39.6

39.8

0.07

576

(3026008) Bacteria identified in Urine by Culture

201

1.59

1.12

3.1

2.2

—

(40758558) Short blood count panel - Blood

175

1.61

1.10

7.9

5.0

—

(42529406) Shigella sp [Presence] in Stool by Culture

2.47

1.10

1.0

1.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

384

1.52

1.04

8.0

8.4

4.2

3.9

e9/l

0.38

338

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

677

1.86

1.01

4.2

4.0

—

(3001019) Free T4 and TSH panel - Serum or Plasma

2.03

0.99

1.6

1.5

—

(40761511) CBC panel - Blood by Automated count

704

1.94

0.98

12.3

8.3

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

338

1.49

0.98

3.6

6.1

6.0

6.2

mmol/l

0.17

291

(3044640) Blood type and Crossmatch panel - Blood

164

1.56

0.93

2.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

121

1.62

0.92

2.3

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

2.15

0.91

1.5

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

131

1.58

0.88

3.5

2.5

22.9

75.4

ug/g

2.68

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.69

0.84

1.2

1.7

—

(3023368) Bacteria identified in Blood by Culture

116

1.59

0.82

4.5

3.7

—

(3022145) Colonoscopy Study observation

1.74

0.81

1.6

1.3

—

(3032080) INR in Blood by Coagulation assay

152

1.51

0.79

3.4

4.2

1.0

inr

—

(3020779) Urea [Moles/volume] in Serum or Plasma

1.82

0.78

6.0

12.9

5.9

5.8

mmol/l

—

(1002224) Polysomnography panel

2.25

0.77

1.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

321

1.41

0.76

6.5

8.1

0.0

e9/l

0.00

260

(3022621) pH of Urine by Test strip

1.92

0.76

7.6

2.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

2.06

0.74

1.4

1.2

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

2.06

0.74

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

209

0.66

0.71

2.3

1.7

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.77

0.65

6.4

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.77

0.65

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.00

0.61

0.0

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.9

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.60

0.0

1.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

1.61

0.58

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

263

0.73

0.55

2.0

1.8

—

(3008898) HLA-B27 [Presence]

1.58

0.54

1.0

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

106

0.63

0.53

1.3

1.5

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.53

0.49

5.7

2.6

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

540

1.32

0.49

11.5

7.2

106.4

102.8

ml/min/173m2

0.60

389

(3021879) Hepatitis B virus core Ab [Presence] in Serum

0.59

0.48

1.4

—

(3007164) IgA [Mass/volume] in Serum or Plasma

223

1.31

0.48

1.3

1.4

1.8

1.9

g/l

0.37

119

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

141

1.35

0.45

1.8

2.4

0.5

0.9

mg/l

1.26

100

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1.49

0.44

8.3

8.9

1.1

1.2

mmol/l

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

293

1.27

0.44

4.9

4.6

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

255

1.28

0.43

5.9

3.2

—

(3000492) Spirometry study

1.37

0.42

1.0

1.2

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(40768793) Breast Pathology biopsy report

0.00

0.41

0.0

1.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

1.50

0.41

2.2

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.50

0.41

2.6

1.5

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.41

0.0

1.9

—

6.5

—

(3012516) Albumin [Mass/volume] in Urine

1.39

0.40

5.0

3.6

187.9

112.7

mg/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.40

0.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1.38

0.40

1.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.65

0.37

1.2

1.7

—

(3020682) Albumin/Creatinine [Ratio] in Urine

100

1.36

0.36

5.5

4.3

27.7

21.1

mg/mmol

—

(3000991) Gas panel - Venous blood

1.36

0.34

12.3

10.7

—

(3013512) EKG study

1.36

0.34

4.0

2.9

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1.33

0.34

4.7

11.7

21.4

25.3

mmol/l

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

351

1.21

0.32

2.7

2.2

—

(3003694) ABO and Rh group [Type] in Blood

267

0.81

0.32

2.4

1.8

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

151

0.76

0.31

1.6

—

(40761536) Microorganisms panel - Urine sediment

0.70

0.27

5.0

3.1

—

(3029937) Albumin [Presence] in Urine by Test strip

190

1.21

0.26

7.1

3.3

0.0

estimate

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.26

0.26

1.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

1.30

0.23

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

174

1.20

0.22

1.9

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

0.00

0.21

0.0

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

0.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.3

—

(3035637) Corticotropin [Mass/volume] in Plasma

0.00

0.21

0.0

1.9

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

0.00

0.21

0.0

3.2

—

3.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

0.00

0.21

0.0

3.3

—

54.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.3

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

174

0.83

0.20

1.6

—

(3012544) pH of Venous blood

1.20

0.18

8.3

9.2

—

(3002256) Pathology report gross observation

1.16

0.18

1.0

1.1

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.21

0.17

1.3

1.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.18

0.12

1.8

2.1

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

252

1.11

0.11

1.3

1.5

1.1

1.6

u/ml

—

(3019832) Treponema pallidum Ab [Presence] in Serum

267

0.91

0.10

2.1

1.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.09

0.10

1.6

11.5

105.8

104.4

mmol/l

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.82

0.07

1.7

1.6

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

143

1.06

0.01

1.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

173

1.05

0.01

2.1

4.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

664

1.05

0.00

15.4

9.9

18.9

21.1

mg/l

0.26

474

(3041096) Erythrocytes [Presence] in Urine by Automated

197

1.02

0.00

4.8

2.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

2.3

—

14.0

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

0.00

0.0

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

0.0

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.95

0.00

1.8

1.6

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.0

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.8

—

(36660697) Celiac disease serology panel - Serum

0.96

0.00

1.4

1.1

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.00

0.0

1.1

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.91

0.00

1.7

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

0.0

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

0.00

0.0

2.3

—

2.0

—

(40768441) Liver Pathology biopsy report

0.00

0.0

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

0.00

0.0

10.7

—

59.0

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.0

1.4

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.3

—

(3005033) Fetal Nuchal fold Thickness US

0.97

0.00

1.8

1.5

—

(21494755) Public health laboratory ask at order entry panel

0.91

0.00

1.3

—

(3029075) Extractable nuclear Ab panel - Serum

0.00

0.0

1.2

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

0.00

0.0

1.3

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.00

0.0

1.2

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

0.00

0.0

1.8

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3011648) Oxygen content in Venous blood

0.00

0.0

39.0

—

12.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.97

0.00

1.8

1.5

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.00

0.0

1.2

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.00

0.0

1.3

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

0.00

0.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

1.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.3

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

112.8

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

6.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.0

4.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

0.00

0.0

1.0

—

(4146454)

0.00

0.0

4.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

1714.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

0.0

1.6

—

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.91

0.00

1.7

1.5

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

0.00

0.0

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.91

0.00

1.7

1.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

11.3

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.91

0.00

1.7

1.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.4

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SLEEPTERRORS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have F5_SLEEPTERRORS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: F5_SLEEPTERRORS – Sleep terrors [night terrors]

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleep terrors [night terrors]

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints